GHRS: GH Research PLC Stock

by  •  • Comments Off on GHRS: GH Research PLC Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 868.39
Enterprise Value ($M) 778.34
Book Value ($M) 189.37
Book Value / Share 3.05
Price / Book 4.59
NCAV ($M) 144.70
NCAV / Share 2.33
Price / NCAV 6.00

Profitability (mra)
Return on Invested Capital (ROIC) -0.22
Return on Assets (ROA) -0.18
Return on Equity (ROE) -0.19

Liquidity (mrq)
Quick Ratio 15.83
Current Ratio 15.83

Balance Sheet (mrq) ($M)
Current Assets 154.95
Assets 199.61
Liabilities 10.24
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-12 13G/A Fmr Llc
02-10 13G/A Lynx1 Capital Management LP
11-14 13G/A Ra Capital Management, L.p. 12.90 19.68
2024-02-14 13G Rtw Investments, Lp 6.40
2024-02-14 13G/A Biotechnology Value Fund L P 19.99 12.13
2024-02-14 13G/A Venrock Healthcare Capital Partners II, L.P. 2.50 -62.52

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-02-21 80,270 368,448 21.79
2025-02-20 47,058 261,052 18.03
2025-02-19 78,245 230,817 33.90
2025-02-18 57,619 186,556 30.89

(click for more detail)

Similar Companies
FOLD – Amicus Therapeutics, Inc. FULC – Fulcrum Therapeutics, Inc.
GANX – Gain Therapeutics, Inc. HCWB – HCW Biologics Inc.
HRMY – Harmony Biosciences Holdings, Inc.


Financial data and stock pages provided by
Fintel.io